Patents by Inventor Woon-Kai Low

Woon-Kai Low has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8841285
    Abstract: Provided herein include compositions, all related stereoisomers as well as pharmaceutically acceptable salts provided as simplified analogs of pateamine A, in which the analogs generally are devoid of the C3-amino and C5-methyl groups, also referred to as desmethyl, desamino-pateamine A. Suitable analogs provide anticancer and antiproliferative effects in vivo and in vitro by a novel drugs mechanism of action described herein for pateamine A, including inhibition of eIF4A-dependent translation initiation. As with pateamine A, as described herein, suitable analogs cause cell cycle arrest or induce apoptosis in transformed cells. However, toxicity of such compounds to slow growing normal cells is low. In addition, such analogs, like pateamine A, target translation initiation factors and are useful as anticancer and antiproliferative agents in subjects in need thereof.
    Type: Grant
    Filed: June 11, 2010
    Date of Patent: September 23, 2014
    Assignees: The Texas A&M University System, The John Hopkins University
    Inventors: Daniel Romo, Jun Liu, Nam Song Choi, Zonggao Shi, Woon-Kai Low, Yongjun Dang, Tilman Schneider-Poetsch
  • Publication number: 20110053994
    Abstract: Provided herein include compositions, all related stereoisomers as well as pharmaceutically acceptable salts provided as simplified analogs of pateamine A, in which the analogs generally are devoid of the C3-amino and C5-methyl groups, also referred to as desmethyl, desamino-pateamine A. Suitable analogs provide anticancer and antiproliferative effects in vivo and in vitro by a novel drugs mechanism of action described herein for pateamine A, including inhibition of eIF4A-dependent translation initiation. As with pateamine A, as described herein, suitable analogs cause cell cycle arrest or induce apoptosis in transformed cells. However, toxicity of such compounds to slow growing normal cells is low. In addition, such analogs, like pateamine A, target translation initiation factors and are useful as anticancer and antiproliferative agents in subjects in need thereof.
    Type: Application
    Filed: June 11, 2010
    Publication date: March 3, 2011
    Applicants: THE TEXAS A & M UNIVERSITY SYSTEM, JOHNS HOPKINS UNIVERSITY, THE
    Inventors: Daniel Romo, Jun Liu, Nam Song Choi, Zonggao Shi, Woon-Kai Low, Yongjun Dang, Tilman Schneider-Poetsch
  • Patent number: 7737134
    Abstract: Provided herein are compositions, all related stereoisomers as well as pharmaceutically acceptable salts provided as simplified analogs of pateamine A, in which the analogs generally are devoid of the C3-amino and C5-methyl groups, also referred to as desmethyl, desamino-pateamine A. Suitable analogs provide anticancer and antiproliferative effects in vivo and in vitro by a novel drug mechanism of action described herein for pateamine A, including inhibition of eIF4A-dependent translation initiation. As with pateamine A, as described herein, suitable analogs cause cell cycle arrest or induce apoptosis in transformed cells. However, toxicity of such compounds to slow growing normal cells is low. In addition, such analogs, like pateamine A, target translation initiation factors and are useful as anticancer and antiproliferative agents in subjects in need thereof.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: June 15, 2010
    Assignees: The Texas A & M University System, The Johns Hopkins University
    Inventors: Daniel Romo, Jun Liu, Nam Song Choi, Zonggao Shi, Woon-Kai Low, Yongjun Dang, Tilman Schneider-Poetsch
  • Publication number: 20070149581
    Abstract: Provided herein include compositions, all related stereoisomers as well as pharmaceutically acceptable salts provided as simplified analogs of pateamine A, in which the analogs generally are devoid of the C3-amino and C5-methyl groups, also referred to as desmethyl, desamino-pateamine A. Suitable analogs provide anticancer and antiproliferative effects in vivo and in vitro by a novel drugs mechanism of action described herein for pateamine A, including inhibition of eIF4A-dependent translation initiation. As with pateamine A, as described herein, suitable analogs cause cell cycle arrest or induce apoptosis in transformed cells. However, toxicity of such compounds to slow growing normal cells is low. In addition, such analogs, like pateamine A, target translation initiation factors and are useful as anticancer and antiproliferative agents in subjects in need thereof.
    Type: Application
    Filed: October 6, 2006
    Publication date: June 28, 2007
    Applicant: The Texas A&M University System
    Inventors: Daniel Romo, Jun Liu, Nam Choi, Zonggao Shi, Woon-Kai Low, Yongjun Dang, Tilman Schneider-Poetsch